SE0302331D0 - New use II - Google Patents

New use II

Info

Publication number
SE0302331D0
SE0302331D0 SE0302331A SE0302331A SE0302331D0 SE 0302331 D0 SE0302331 D0 SE 0302331D0 SE 0302331 A SE0302331 A SE 0302331A SE 0302331 A SE0302331 A SE 0302331A SE 0302331 D0 SE0302331 D0 SE 0302331D0
Authority
SE
Sweden
Prior art keywords
new use
angiotensin
prevention
type
myocardial infarction
Prior art date
Application number
SE0302331A
Other languages
English (en)
Inventor
John Mcmurray
Jan Oestergren
Marc A Pfeffer
Karl Swedberg
Christopher B Granger
Salim Yusuf
Peter Held
Eric L Michelson
Bertil Olofsson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0302331A priority Critical patent/SE0302331D0/sv
Publication of SE0302331D0 publication Critical patent/SE0302331D0/sv
Priority to PCT/SE2004/001228 priority patent/WO2005020971A1/en

Links

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0302331A 2003-08-29 2003-08-29 New use II SE0302331D0 (sv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0302331A SE0302331D0 (sv) 2003-08-29 2003-08-29 New use II
PCT/SE2004/001228 WO2005020971A1 (en) 2003-08-29 2004-08-25 Use of an angiotensin ii antagonist for the prevention of myocardial infarction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0302331A SE0302331D0 (sv) 2003-08-29 2003-08-29 New use II

Publications (1)

Publication Number Publication Date
SE0302331D0 true SE0302331D0 (sv) 2003-08-29

Family

ID=28673224

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0302331A SE0302331D0 (sv) 2003-08-29 2003-08-29 New use II

Country Status (2)

Country Link
SE (1) SE0302331D0 (sv)
WO (1) WO2005020971A1 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2246742B1 (es) * 2005-09-06 2007-02-01 Prous Institute For Biomedical Research S.A. Uso de un derivado de imidazol.
US8338565B2 (en) 2008-08-20 2012-12-25 Ensemble Therapeutics Corporation Macrocyclic compounds for inhibition of tumor necrosis factor alpha
EP2999435B1 (en) 2013-05-20 2022-12-21 Twelve, Inc. Implantable heart valve devices, mitral valve repair devices and associated systems
CN117607311B (zh) * 2024-01-19 2024-03-29 地奥集团成都药业股份有限公司 一种盐酸贝那普利对映异构体的检测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ513039A (en) * 1999-01-26 2003-11-28 Novartis Ag Use of angiotensin II receptor antagonists for treating acute myocardial infarction
GB0020691D0 (en) * 2000-08-22 2000-10-11 Boehringer Ingelheim Pharma Pharmaceutical combination

Also Published As

Publication number Publication date
WO2005020971A1 (en) 2005-03-10

Similar Documents

Publication Publication Date Title
DE60142921D1 (de) Azaphenanthridone-derivate und deren verwendung als parp-inhibitoren
PL361404A1 (en) Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
UA93351C2 (uk) Похідні фталазіну як інгібітори parp
DE60332604D1 (de) Azolylaminoazine als proteinkinasehemmer
JO3492B1 (ar) تركيبات صيدلانية من مضاد مستقبل أنجيوتنسين ومثبط nep
ATE430747T1 (de) 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren
IL152916A0 (en) Heteroaryl-phenyl heterobicyclic factor xa inhibitors
DE60309848D1 (de) Purinderivate als kinaseinhibitoren
ATE400567T1 (de) Kinaseinhibitoren
NO20076554L (no) Pyrimidin- eller triazinkondenserte, bisykliske metalloproteaseinhibitorer
TW200612950A (en) Quinazolinedione derivatives as PARP inhibitors
MX2008014873A (es) Inhibidores de metaloproteasa heterobiciclicas.
BR0211274A (pt) Combinação de um antagonista de receptor de aldosterona e um inibidor de hmg co-a redutase
ATE371656T1 (de) Heteroaryl-pyrimidinderivate als jak-inhibitoren
WO2003065987A3 (en) Granzyme b inhibitors
ATE411030T1 (de) Phosphonatanaloga von hiv- integrasehemmerverbindungen
TR201907381T4 (tr) Beta-laktamil fenilalanin, sistein ve serin vazopressin antagonisti.
MY143516A (en) Kinase inhibitors
IL163777A0 (en) Kinase inhibitors
WO2002015891A3 (en) Pharmaceutical combination of angiotensin ii antagonists and ace inhibitors
ATE438398T1 (de) Pyrrolo-dihydroisochinolin-derivate als pde10- inhibitoren
DE60313350D1 (de) Pyrimidin-2,4-dion-derivate als matrix-metalloproteinase-hemmer
BR9809848A (pt) Composição
TW200507855A (en) Combination of an aldosterone receptor antagonist and a neutral endopeptidase inhibitor
DE60215368D1 (de) Pyranderivate als inhibitoren von ace und nep